Clinical trial
Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
NCT00012558 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00012558 |
|---|---|
| Title | Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) |
| Official title | Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Behavioral, Drug |
| Interventions | lithium, valproate, bupropion, paroxetine, lamotrigine, risperidone, inositol, tranylcypromine, Cognitive Behavioral Therapy, Family-focused Therapy and 1 more |
| Enrollment | 5,000 |
| Start date | Sep 1, 1998 |
| Completion | Sep 1, 2005 |
| First posted | Mar 15, 2001 |
| Last update posted | May 4, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: